Search research articles
Contact Us
Filters
Showing results (41-50 of 143) with videos related to
Page
of 15
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Clinical Manifestations
Michael H Malek-Ahmadi, Angela Kuramoto, Farah Shaikh, et al.
Nature Reviews. Neurology
|
November 3, 2025
Towards pharmacological prevention of Alzheimer disease
Jorge J Llibre-Guerra, Eric M McDade, Suzanne E Schindler, et al.
Alzheimer'S Research & Therapy
|
April 20, 2022
Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease
Sheila Seleri Assunção, Reisa A Sperling, Craig Ritchie, et al.
Alzheimer'S Research & Therapy
|
November 27, 2018
Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical program
Jeffrey L Cummings, Alireza Atri, Clive Ballard, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 14, 2026
Gray matter microstructure from in vivo diffusion magnetic resonance imaging reflects post mortem neuropathology severity and clinical progression of Alzheimer's disease
Zaki Alasmar, Cécilia Tremblay, Roqaie Moqadam, et al.
Thyroid : Official Journal of the American Thyroid Association
|
January 27, 2005
Thyroid nodule shape and prediction of malignancy
Erik K Alexander, Ellen Marqusee, Joseph Orcutt, et al.
Alzheimer'S Research & Therapy
|
January 9, 2025
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease
Jeffrey L Cummings, Alireza Atri, Howard H Feldman, et al.
Neurology. Clinical Practice
|
May 13, 2026
Clinical Meaningfulness of Donanemab in Early Symptomatic Alzheimer Disease: Data From the Randomized Phase 3 TRAILBLAZER-ALZ 2 Trial
Alireza Atri, Liana G Apostolova, Atsushi Iwata, et al.
Acta Neuropathologica Communications
|
June 30, 2025
Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort
Divya Bali, Gemma Salvadó, Thomas G Beach, et al.
CNS Spectrums
|
February 16, 2017
Approach to atypical Alzheimer's disease and case studies of the major subtypes
Bradford C Dickerson, Scott M McGinnis, Chenjie Xia, et al.
Page
of 15
Search research articles
Search
Showing results (41-50 of 143) with videos related to
Sort By:
Page
of 15
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Clinical Manifestations
Michael H Malek-Ahmadi, Angela Kuramoto, Farah Shaikh, et al.
Nature Reviews. Neurology
|
November 3, 2025
Towards pharmacological prevention of Alzheimer disease
Jorge J Llibre-Guerra, Eric M McDade, Suzanne E Schindler, et al.
Alzheimer'S Research & Therapy
|
April 20, 2022
Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease
Sheila Seleri Assunção, Reisa A Sperling, Craig Ritchie, et al.
Alzheimer'S Research & Therapy
|
November 27, 2018
Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical program
Jeffrey L Cummings, Alireza Atri, Clive Ballard, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 14, 2026
Gray matter microstructure from in vivo diffusion magnetic resonance imaging reflects post mortem neuropathology severity and clinical progression of Alzheimer's disease
Zaki Alasmar, Cécilia Tremblay, Roqaie Moqadam, et al.
Thyroid : Official Journal of the American Thyroid Association
|
January 27, 2005
Thyroid nodule shape and prediction of malignancy
Erik K Alexander, Ellen Marqusee, Joseph Orcutt, et al.
Alzheimer'S Research & Therapy
|
January 9, 2025
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease
Jeffrey L Cummings, Alireza Atri, Howard H Feldman, et al.
Neurology. Clinical Practice
|
May 13, 2026
Clinical Meaningfulness of Donanemab in Early Symptomatic Alzheimer Disease: Data From the Randomized Phase 3 TRAILBLAZER-ALZ 2 Trial
Alireza Atri, Liana G Apostolova, Atsushi Iwata, et al.
Acta Neuropathologica Communications
|
June 30, 2025
Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort
Divya Bali, Gemma Salvadó, Thomas G Beach, et al.
CNS Spectrums
|
February 16, 2017
Approach to atypical Alzheimer's disease and case studies of the major subtypes
Bradford C Dickerson, Scott M McGinnis, Chenjie Xia, et al.
Page
of 15